Discovery of new quinoline ether inhibitors with high affinity and selectivity for PDGFR tyrosine kinases

Patrick A Plé1, Frédéric Jung, Sue Ashton

  • 1AstraZeneca, Centre de Recherches, BP 1050, 51689 Reims Cedex 2, France. patrick.ple@astrazeneca.com